Cargando…
Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
BACKGROUND: Malignant gliomas are the most prevalent type of primary brain tumours but the therapeutic armamentarium for these tumours is limited. Platelet-derived growth factor (PDGF) signalling has been shown to be a key regulator of glioma development. Clinical trials evaluating the efficacy of a...
Autores principales: | Martinho, O, Longatto-Filho, A, Lambros, M B K, Martins, A, Pinheiro, C, Silva, A, Pardal, F, Amorim, J, Mackay, A, Milanezi, F, Tamber, N, Fenwick, K, Ashworth, A, Reis-Filho, J S, Lopes, J M, Reis, R M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743351/ https://www.ncbi.nlm.nih.gov/pubmed/19707201 http://dx.doi.org/10.1038/sj.bjc.6605225 |
Ejemplares similares
-
Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
por: Longatto-Filho, Adhemar, et al.
Publicado: (2009) -
EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma
por: Gai, Qu-Jing, et al.
Publicado: (2022) -
The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
por: Disel, Umut, et al.
Publicado: (2019) -
Molecular Alterations of KIT Oncogene in Gliomas
por: Gomes, Ana L., et al.
Publicado: (2007) -
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
por: Elsheikh, S E, et al.
Publicado: (2008)